George Cholankeril1, Humberto C Gonzalez2, Sanjaya K Satapathy2, Stevan A Gonzalez3, Menghan Hu4, Mohammad Ali Khan2, Eric R Yoo1, Andrew A Li1, Donghee Kim1, Satheesh Nair2, Robert J Wong5, Paul Y Kwo1, Stephen A Harrison6, Zobair M Younossi7, Keith D Lindor8, Aijaz Ahmed9. 1. Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California. 2. Department of Transplant Surgery, Methodist University Hospital, University of Tennessee Health Science Center, Memphis, Tennessee. 3. Baylor Simmons Transplant Institute, Fort Worth, Texas. 4. Department of Biostatistics, Brown University School of Public Health, Providence, Rhode Island. 5. Division of Gastroenterology and Hepatology, Alameda Health System, Highland Hospital, Oakland, California. 6. Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom. 7. Department of Medicine, Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, Virginia. 8. Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Arizona State University, Phoenix, Arizona. 9. Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California. Electronic address: aijazahmed@stanford.edu.
Abstract
BACKGROUND & AIMS: Data on the differences in ethnicity and race among patients with primary biliary cholangitis (PBC) awaiting liver transplantation (LT) are limited. We evaluated liver transplant waitlist trends and outcomes based on ethnicity and race in patients with PBC in the United States. METHODS: Using the United Network for Organ Sharing (UNOS) registry, we collected data on patients with PBC on the liver transplant waitlist, and performed analysis with a focus on ethnicity and race-based variations clinical manifestations, waitlist mortality and LT rates from 2000 to 2014. Outcomes were adjusted for demographics, complications of portal hypertension, and Model for End-stage Liver Disease score at time of waitlist registration. RESULTS: Although the number of white PBC waitlist registrants and additions decreased from 2000 to 2014, there were no significant changes in the number of Hispanic PBC waitlist registrants and additions each year. The proportion of Hispanic patients with PBC on the liver transplant waitlist increased from 10.7% in 2000 to 19.3% in 2014. Hispanics had the highest percentage of waitlist deaths (20.8%) of any ethnicity or race evaluated. After adjusting for demographic and clinical characteristics, Hispanic patients with PBC had the lowest overall rate for undergoing LT (adjusted hazard ratio, 0.71; 95% CI, 0. 60-0.83; P < .001) and a significantly higher risk of death while on the waitlist, compared to whites (adjusted hazard ratio, 1.41; 95% CI, 1.15-1.74; P < .001). Furthermore, Hispanic patients with PBC had the highest proportion of waitlist removals due to clinical deterioration. CONCLUSIONS: In an analysis of data from UNOS registry focusing on outcomes, we observed differences in rates of LT and liver transplant waitlist mortality of Hispanic patients compared with white patients with PBC. Further studies are needed to improve our understanding of ethnicity and race-based differences in progression of PBC.
BACKGROUND & AIMS: Data on the differences in ethnicity and race among patients with primary biliary cholangitis (PBC) awaiting liver transplantation (LT) are limited. We evaluated liver transplant waitlist trends and outcomes based on ethnicity and race in patients with PBC in the United States. METHODS: Using the United Network for Organ Sharing (UNOS) registry, we collected data on patients with PBC on the liver transplant waitlist, and performed analysis with a focus on ethnicity and race-based variations clinical manifestations, waitlist mortality and LT rates from 2000 to 2014. Outcomes were adjusted for demographics, complications of portal hypertension, and Model for End-stage Liver Disease score at time of waitlist registration. RESULTS: Although the number of white PBC waitlist registrants and additions decreased from 2000 to 2014, there were no significant changes in the number of Hispanic PBC waitlist registrants and additions each year. The proportion of Hispanic patients with PBC on the liver transplant waitlist increased from 10.7% in 2000 to 19.3% in 2014. Hispanics had the highest percentage of waitlist deaths (20.8%) of any ethnicity or race evaluated. After adjusting for demographic and clinical characteristics, Hispanic patients with PBC had the lowest overall rate for undergoing LT (adjusted hazard ratio, 0.71; 95% CI, 0. 60-0.83; P < .001) and a significantly higher risk of death while on the waitlist, compared to whites (adjusted hazard ratio, 1.41; 95% CI, 1.15-1.74; P < .001). Furthermore, Hispanic patients with PBC had the highest proportion of waitlist removals due to clinical deterioration. CONCLUSIONS: In an analysis of data from UNOS registry focusing on outcomes, we observed differences in rates of LT and liver transplant waitlist mortality of Hispanic patients compared with white patients with PBC. Further studies are needed to improve our understanding of ethnicity and race-based differences in progression of PBC.
Authors: Krystal L Karunungan; Yas Sanaiha; Roland A Hernandez; Holly Wilhalme; Sarah Rudasill; Joseph Hadaya; Joseph DiNorcia; Peyman Benharash Journal: Liver Transpl Date: 2020-12-31 Impact factor: 5.799
Authors: Nabil Noureddin; Ju Dong Yang; Naim Alkhouri; Samantha M Noreen; Alice E Toll; Tsuyoshi Todo; Walid Ayoub; Alexander Kuo; Georgios Voidonikolas; Honore G Kotler; Michalyn D Pelphrey; Brenda J Durand; Kambiz Kosari; Todd V Brennan; Irene Kim; Andrew S Klein; Ekihiro Seki; Nicholas N Nissen; Shelly C Lu; Vinay Sundaram; Mazen Noureddin Journal: Transplant Direct Date: 2020-10-08
Authors: Kristin E Morrill; Victoria L Bland; Yann C Klimentidis; Melanie D Hingle; Cynthia A Thomson; David O Garcia Journal: Int J Environ Res Public Health Date: 2021-07-01 Impact factor: 4.614
Authors: Chung Sang Tse; Ju Dong Yang; Omar Y Mousa; Kevin M Nelson; Surakit Pungpapong; Andrew Keaveny; Bashar A Aqel; Hugo Vargas; Rolland C Dickson; Kymberly Watt; Gregory J Gores; Lewis R Roberts; Michael D Leise Journal: Transplant Direct Date: 2020-12-08
Authors: Christine Park; Mandisa-Maia Jones; Samantha Kaplan; Felicitas L Koller; Julius M Wilder; L Ebony Boulware; Lisa M McElroy Journal: Int J Equity Health Date: 2022-02-12